New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
07:59 EDTMDT, AGN, ABT, PFE, PRGO, ABBV, MYL, COV, VRX, SHPG, AZNTreasury Secretary urges Congress to take action on tax inversions
Treasury Secretary Jack Lew, in a letter to Senate Finance Committee Chairman Ron Wyden and others, urged Congress to take action to address the "urgent issue" of tax inversions, which Lew said "function to hollow out the U.S. corporate income tax base." Lew noted that President Obama proposes to ensure that companies cannot change their tax domicile without a change in control of the company. According to Lew, several senators have "put companies on notice that any transaction that takes place after early May will not have the desired effect of lowering future U.S. tax liabilities." Tax inversions are a particularly significant issue in the pharmaceutical industry. Companies that have recently proposed transactions that involve an inversion component or have been linked to potential transactions include Pfizer (PFE), AstraZeneca (AZN), Mylan (MYL), Abbott (ABT), Shire (SHPG), AbbVie (ABBV), Allergan (AGN), Valeant (VRX), Perrigo (PRGO), Medtronic (MDT) and Covidien (COV). Reference Link
News For PFE;AZN;MYL;ABT;SHPG;ABBV;AGN;VRX;PRGO;MDT;COV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
November 11, 2014
08:13 EDTABBVAbbVie announces positive results from Phase 2b study PEARL-I
Subscribe for More Information
08:11 EDTABBVEnanta announces rseults from Phase 2b PEARL-I study
Subscribe for More Information
07:24 EDTCOV, MDTMedtronic submits commitments to EU related to Covidien merger
Subscribe for More Information
November 10, 2014
15:54 EDTCOVAmerican Society of Nephrology to hold a conference
Subscribe for More Information
15:53 EDTPRGOCredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 11 at 10:30 am; not all company presentations may be webcasted. Webcast Link
09:10 EDTMDTMedtronic announces Japanese approval, launch of Evera MRI SureScan ICD
Subscribe for More Information
08:36 EDTCOVBSD Medical names Clint Carnell as president and CEO
Subscribe for More Information
07:19 EDTPRGOCredit Suisse to hold a conference
Subscribe for More Information
November 9, 2014
13:26 EDTVRX, AGNAckman's Allergan court win may prove costly down the road, Bloomberg says
When U.S. District Court Judge David Carter ruled on November 4 that Pershing Square can vote its 9.7% stake in Allergan (AGN) in a shareholder ballot aiming to remove Allergan directors, he also noted that there were “serious questions” regarding insider trading rules in the way Pershing Square acquired Allergan stock while preparing a bid with Valeant (VRX), says Bloomberg. Reference Link
November 7, 2014
17:05 EDTVRXValeant sends open letter to physician customers
Subscribe for More Information
14:56 EDTVRX, AGNAllergan says Valeant offers to date inadequate, would consider increased bid
Subscribe for More Information
10:00 EDTPRGOOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Antero Resources (AR) upgraded to Overweight from Equalweight at Capital One... CA Technologies (CA) upgraded at Evercore ISI... CGG SA (CGG) upgraded to Hold from Sell at Canaccord... Cavium (CAVM) upgraded to Strong Buy from Outperform at Raymond James... Charter (CHTR) upgraded to Outperform from Market Perform at Raymond James... Chesapeake (CHK) upgraded to Overweight from Equal Weight at Johnson Rice... Container Store (TCS) upgraded at BofA/Merrill... Delhaize (DEG) upgraded to Neutral from Underperform at BofA/Merrill... Devon Energy (DVN) upgraded to Accumulate from Hold at Tudor Pickering... Dynegy (DYN) upgraded to Accumulate from Hold at Tudor Pickering... EOG Resources (EOG) upgraded to Buy from Accumulate at Tudor Pickering... Envestnet (ENV) upgraded at Raymond James... GNC Holdings (GNC) upgraded to Buy from Neutral at Goldman... Hospira (HSP) upgraded at Raymond James... Kinross Gold (KGC) upgraded to Buy from Neutral at UBS... Kosmos (KOS) upgraded at RBC Capital... Nationstar (NSM) upgraded to Market Perform from Underperform at Wells Fargo... Northern Oil and Gas (NOG) upgraded at Raymond James... Perrigo (PRGO) upgraded to Overweight from Equal Weight at Morgan Stanley... PetSmart (PETM) upgraded to Hold from Sell at Deutsche Bank... Plains GP Holdings (PAGP) upgraded at Credit Suisse... Rosetta Resources (ROSE) upgraded to Accumulate from Hold at Tudor Pickering... Splunk (SPLK) upgraded to Buy from Hold at Evercore ISI... Sunoco Logistics (SXL) upgraded to Buy from Neutral at UBS... Target (TGT) upgraded to Buy from Neutral at Cleveland Research... Walker & Dunlop (WD) upgraded to Outperform from Market Perform at Wells Fargo... XO Group (XOXO) upgraded to Buy from Neutral at B. Riley... Zynga (ZNGA) upgraded to Buy from Hold at Needham.
10:00 EDTABBVOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:49 EDTAGN, VRXAckman says Allergan 'tipping scales' in Actavis’ favor, disadvantaging Valeant
Subscribe for More Information
09:09 EDTABBVAbbVie downgraded to Market Perform at BMO Capital
Subscribe for More Information
08:21 EDTPRGOPerrigo upgraded to Overweight from Equal Weight at Morgan Stanley
Subscribe for More Information
08:01 EDTMYLMylan signs alliance agreement with Disney Parks to enhance EpiPen access
Subscribe for More Information
07:57 EDTPRGOPerrigo upgraded to Overweight from Equal Weight at Morgan Stanley
Subscribe for More Information
06:47 EDTPRGOPerrigo price target raised to $207 from $189 at Deutsche Bank
Deutsche Bank raised its price target for Perrigo shares to $207 citing the company's Q1 results and planned acquisition of Omega Pharma. Deutsche says the acquisition will accelerate Perrigo's expansion into the European over-the-counter market, which the firm calls "large and durable." It reiterates a Buy rating on Perrigo.
06:26 EDTABBVAbbVie downgraded to Market Perform from Outperform at BMO Capital
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use